Email: vanagno1@jhmi.edu

Education

• MD; National and Kapodistrian University of Athens School of Medicine (2005)
• PhD; National and Kapodistrian University of Athens School of Medicine (2011)
• Residency, Internal Medicine; Yale-New Haven Hospital (2013)
• Fellowship, Medical Oncology; Johns Hopkins University School of Medicine (2016)

Board Certifications

• American Board of Internal Medicine (General Internal Medicine) (2014)
• American Board of Internal Medicine (Medical Oncology) (2015)

Education:

• BS, Electrical Engineering, Sharif University of Technology, Tehran, Iran
• MS, Biomedical Engineering, Johns Hopkins University, Baltimore, MD
• PhD, Biomedical Engineering, Johns Hopkins University, Baltimore, MD

Bio: Noushin is a bioinformatics scientist with a background in computational molecular medicine. She focuses on development and application of bioinformatics and statistical methodologies in the field of cancer genomics investigating questions related to cancer early detection, tumor evolution, treatment response prediction and monitoring.

Education:

• BS, Cell and Molecular Biology, Towson University, Towson, Maryland

Bio: Gavin is interested in early detection of cancer using liquid biopsy approaches in addition to exploring precision medicine in oncology.

Education:

• BA, Psychology, Carleton College, Northfield, MN

Education:

• MHS, Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
• BS, Double Major in Biology and Psychology, School of Biological Sciences, Nanyang Technological University, Singapore

Bio: Shreshtha aspires to become a physician-scientist (MD, PhD) specializing in oncology. Her research interests involve unraveling the causes of pathological disorders and developing effective treatment approaches, particularly within the field of oncology.

Education:

• MD, University of Balamand, Lebanon
• BS, Chemical Engineering, University of Balamand, Lebanon

Bio: Mimi is interested in studying the genetic factors that influence responses to immunotherapy through integrative genomic exploration. She is particularly interested in translating scientific research into innovative clinical applications, contributing to improved patient care, and promoting personalized medicine.

Education:

• Ph.D. Cancer Biology and Molecular Genetics, Barts and the London School of Medicine, Queen Mary University of London

Previous Institutions:

• Barts and the London School of Medicine, Queen Mary University of London

Bio: Lavanya is interested in leveraging minimally invasive liquid biopsies to gain real-time insights into tumor burden dynamics and the evolving molecular landscape of cancers during the selective pressure of immunotherapy.

Education:

• MD candidate at National Kapodistrian University of Athens, Greece

Previous Institutions:

• Johns Hopkins University KSAS, Baltimore MD

Research Interests: genotype-matched therapeutic routes, translational genomics technologies, liquid biopsies and ctDNA analyses, precision oncology and patient education initiatives.

Education:

• BS, Loyola University Maryland, Baltimore, MD
• MS, University of Pittsburgh School of Public Health, Pittsburgh, PA

Bio: Jaime is interested in the genetic basis for cancer and how this information can be better used in the treatment, prognosis, and prevention of cancer. She is also interested in new developments in technology and how these can be leveraged in new and exciting ways in scientific research.

Education

• BS, Chemical Engineering, UMBC, Baltimore, MD

Bio: Blair is interested in investigating the interplay between solid tumors and the immune system and how this is related to tumor evolution and anti-tumor immune response.

Education:

• MSE, Biomedical Engineering, Johns Hopkins University, Baltimore, MD

Previous Institutions:

• Indian Institute of Sciences, Bengaluru, India.

Bio: My research interests include developing computational methods and bioinformatics pipelines for cancer genomics. I am particularly interested in leveraging multi-omics data to study mechanisms of resistance in immunotherapy.

Education:

• BS, Molecular and Cellular Biology, Johns Hopkins University, Baltimore, MD

Previous Institutions:

• Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Bio: Jinny is broadly interested in developing a tumor-informed, cell free (cfDNA) whole genome sequencing (WGS) multi-feature approach that integrates cfDNA WGS with information about differential fragmentomics and copy number alterations in a machine learning model to capture immunotherapy response and MRD in the metastatic as well as early-stage cancer settings.

Education:

• MS, Bioengineering, Stanford University
• BS, Computer Science, Johns Hopkins University

Bio: Justin is interested in applying computational methods and data analytic techniques to advancing cancer immunotherapies, with a special focus on investigating treatments that may be directly translated into clinical settings.

Bio: Kavya is interested by the cellular mechanisms of oncology, and hopes to further her understanding of cancer therapeutics and therapeutic strategies.

I am honored to be a member of the Johns Hopkins Molecular Tumor Board (2021-present), which reviews cases of patients with advanced disease that have exhausted traditional therapeutic routes, and explores molecularly informed treatment options. Despite the geographical distance, I am grateful to continue to work on the preparation of the cases discussed weekly. During the academic year 2021-2022, I worked as a research assistant at the JH Molecular Oncology Lab, conducting cfDNA extractions from LBs of esophageal ca patients enrolled in an IO clinical trial at JHH. To maintain my exposure to research, I joined UoA’s A’ Pathology Research Lab, focusing on molecular oncology projects.

Education:

• MB BCh BAO, University College Dublin, Ireland.
• Oncology Fellowship, Royal College of Physicians in Ireland.

Bio: Michael is a clinical and research fellow with a focus on thoracic cancers. His current research interests include the use of liquid biopsy in the genomic profiling of lung cancer, the gut microbiome as a prognostic biomarker in non-small cell lung cancer and early phase clinical trials.

Education:

• BS, Biology, Georgetown University, Washington, DC
• MS, Physiology and Biophysics, Georgetown University Washington, DC
• MD, Doctor of Medicine, George Washington University School of Medicine & Health Sciences, Washington, DC

Previous Institutions:

• George Washington University School of Medicine & Health Sciences, Washington, DC
• National Institutes of Health, Division of Cancer Epidemiology & Genetics, Rockville, MD

Bio: Laura is currently working in the genitourinary research group, focused on biomarkers development and early phase clinical trials. In particular, she is interested in exploring epigenetic and genomics targets in traditionally hormone-based malignancies.

Education:

• Bachelor of Medicine & Surgery (M.B.B.Ch), Benha University – Faculty of Medicine, Egypt

Bio: Mohamed’s research is focused on precision oncology, with a particular emphasis on its application in brain cancer. At Johns Hopkins, he is working on developing a comprehensive database for all brain cancer patients, alongside expanding the precision medicine biobank. His work intersects with the Molecular Tumor Board, contributing to the strategic selection of targeted therapies in various cancer types. His efforts aim to advance targeted therapies for cancer treatment.

Education:

• MBBS, Aga Khan University, Karachi, Pakistan

Bio: Amna is interested in understanding the relevant role of genomics in guiding diagnostic and therapeutic interventions that underlie cancer treatment, with a focus on response and resistance to immunotherapy.

Education:

• PhD, Applied Mathematics and Scientific Computation, University of Maryland — College Park

Bio: James is focused on the development of novel computational methods to analyze multi-omics data at the intersection of cancer, immunology and the microbiome.

Education:

• BS, Bioengineering, University of Maryland, College Park, MD
• PhD, Biomedical Engineering, Johns Hopkins University, Baltimore, MD

Previous Institutions:

• James Clark School of Engineering, University of Maryland
• Translational Tissue Engineering Center, Johns Hopkins University

Bio: Chris is interested in analysis of multiomic data with a focus on single cell and spatial data sets.